Biomedical Engineering Reference
In-Depth Information
[49]
Lechpammer, D., and Sgroi, C., ''Laser Capture Microdissection: a rising tool in genetic
profiling of cancer,''
M. Exp. Rev. Mol. Diagn.
, Vol. 4, 2004, pp. 429--430.
[50]
Verhagen, P.C., et al., ''Microdissection, DOP-PCR, and comparative hybridization
of paraffin-embedded familial prostate cancers,''
Cancer Genet. Cytogenet.
, Vol. 122,
2000, pp. 43--48.
[51]
Grønbaek, K., Hother, C., and Jones, P.A, ''Epigenetic changes in cancer,''
APMIS
,Vol.
115, 2007, pp. 1039--1059.
[52]
Shames, D.S., Minna, J.D., and Gazdar, A.F, ''Methods for detecting DNA methylation
in tumors: from bench to bedside,''
Cancer Lett
., Vol. 251, 2007, pp. 187--198.
[53]
Chen, J. Z., Gokden, N., Greene, G. F., Mukunyadzi, P., and Kadlubar, F. F, ''Extensive
Somatic Mitochondrial Mutations in Primary Prostate Cancer Using Laser Capture
Microdissection,''
Cancer Res.
, Vol. 62, 2002, pp. 6470--6474.
[54]
Kreuder, J., Repp, R., Borkhardt, A., and Lampert, F, ''Rapid detection of mitochondrial
deletions by long-distance polymerase chain reaction,''
Eur. J. Ped.
, Vol. 154, 1995,
p. 996.
[55]
Ransohoff, D.F., McNaughton Collins, M., and Fowler, F. J., ''Why is prostate cancer
screening so common when the evidence is so uncertain? A system without negative
feedback,''
Am.J.Med
., Vol. 113, 2002, pp. 663--667.
[56]
Ransohoff, D.F., ''Rules of evidence for cancer molecular-marker discovery and
validation,''
Nat. Rev. Cancer
, Vol. 4, 2004, pp. 309--14.
[57]
Zhang, A., et al., ''Small interfering RNA and gene expression analysis using a multiplex
branched DNA assay without RNA purification,''
J. Biomol. Screen.
, Vol. 10, 2005, pp.
549--556.
[58]
Twombly, R., ''Identity Crisis: Finding, Defining, and Integrating Biomarkers Still a
Challenge,''
J. Natl. Cancer Inst.
, Vol. 98, 2006, pp. 11--12.
[59]
Best, C. J., et al., ''Molecular differentiation of high- and moderate-grade human prostate
cancer by cDNA microarray analysis,''
Diagn. Mol. Pathol.
, Vol. 12, 2003, pp. 63--70.
[60]
Krizman, D.B., et al., ''Construction of a representative cDNA library from prostatic
intraepithelial neoplasia,''
Cancer Res.
, Vol. 56, 1996, pp. 5380--5383.
[61]
Chuaqui, R.F., et al., ''Identification of a novel gene up-regulated in clinically aggressive
human prostate cancer,''
Urology
, Vol. 50, 1997, pp. 301--307.
[62]
Khattra, J., et al., ''Large-scale production of SAGE libraries from microdissected tissues,
flow-sorted cells, and cell lines,''
Genome Res.
, Vol. 17, 2007, pp. 108--116.
[63]
Velculescu, V.E., Zhang, L., Vogelstein, B., and Kinzler, K.W, ''Serial analysis of gene
expression,''
Science
, Vol. 270, 1995, pp. 484--7.
[64]
Granjeaud, S., Bertucci, F., and Jordan, B.R, ''Expression profiling: DNA arrays in many
guises,''
Bioessays
, Vol. 21, 1999, pp. 781--90.
[65]
Lockhart, D.J., et al., ''Expression monitoring by hybridization to high-density
oligonucleotide arrays,''
Nat. Biotechnol.
, Vol. 14, 1996, pp. 1675--1680.
[66]
Cheng, Q., et al., ''Identification and characterization of genes involved in the carcino-
genesis of human squamous cell cervical carcinoma,''
Int. J. Cancer
, Vol. 98, 2002, pp.
419--426.
[67]
Russo, G., Zegar, C., and Giordano, A., ''Advantages and limitations of microarray
technology in human. Cancer,''
Oncogene
, Vol. 22, 2003, pp. 6497--6507.
[68]
Lipshutz, R.J., et al., ''Expression Monitoring by Hybridization to High-Density
Oligonucleotide Arrays,''
Nat. Biotechnol.
, Vol. 14, 1996, pp. 1675--1680.
[69]
Dhanasekaran, S. M., et al., ''Delineation of prognostic biomarkers in prostate cancer,''
Nature
, Vol. 412, 2001, pp. 822--826.
[70]
Luo, J., et al., ''Human prostate cancer and benign prostatic hyperplasia: molecular
dissection by gene expression profiling,''
Cancer Res.
, Vol. 61, 2001, pp. 4683--4688.
Search WWH ::
Custom Search